Genertec Universal Medical Group Company Ltd Financials

Market Capitalization HK$9.12 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	4.46
Forward PE	3.95
Price to Sales TTM	HK$0.69
Price to Book MRQ	HK$0.48
Enterprise to Revenue	4.58
Enterprise to EBITDA	19.57

Financial Reports as of Jun. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-06-30
Profit Margin	16.24%
Operating Margin	20.82%
Return on Assets TTM	2.68%
Return on Equity TTM	10.75%

Income Statement

Revenue TTM	HK$14,170,032,053
Revenue per Share TTM	HK$6.98
Quarterly Revenue Growth	-3.30%
Gross Profit TTM	HK$4,627,755,212
EBITDA	HK$3,318,338,000
Net Income to Common TTM	HK$2,212,051,564
Diluted EPS TTM	HK$1.08
Quarterly Earnings Growth YoY	2.90%

Balance Sheet

Total Cash MRQ	HK$2,739,169,101
Total Cash per Share MRQ	HK$1.35
Total Debt MRQ	HK$
Total Debt to Equity MRQ	227.36
Current Ratio MRQ	2.93
Book Value per Share MRQ	HK$10.11

Cash Flow

Operating Cash Flow TTM	HK$6,853,049,587
Levered Free Cash Flow TTM	HK$2,020,918,000

2666 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	1,891,539,968
Float Shares	918,134,436
Avg 10 Volume	3,722,294
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.60%
% Held by Institutions	5.75%

Stock Price Summary

Beta	0.68
Fifty Two Week Low	HK$3.90
Fifty Two Week High	HK$5.87
Fifty Two Week Change	14.37%
Day 50 MA	HK$4.80
Day 200 MA	HK$4.66

Dividends and Splits

Forward Annual Dividend Rate	HK$1.40
Forward Annual Dividend Yield	28.75%
Trailing Annual Dividend Rate	HK$0.35
Trailing Annual Dividend Yield	7.19%
Payout Ratio	31.94%
Dividend Date
Ex Dividend Date	2024-06-12
Last Split Factor
Last Split Date